CARR EDWARD sold DNTH
March 12, 2026 · Form 4 insider transaction
CARR EDWARD sold 300 shares of Dianthus Therapeutics, Inc. at $85.53 per share, a transaction worth $25.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
300
Price
$85.53
Total value
$25.7K
InsiderCARR EDWARD
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 12, 2026
Filing dateMarch 13, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025.